Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

TAS-108 evaluated in advanced breast cancer

Oct. 27, 2004

Reversal of multidrug resistance in tumor cells by FG-020318

Oct. 27, 2004

Japanese approval for Trisenox

Oct. 27, 2004

Dacogen MAA accepted for review

Oct. 27, 2004

Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene

Oct. 27, 2004

New Eg5 kinesin inhibitors developed by AstraZeneca researchers

Oct. 27, 2004

Approvable letter for Thalomid sNDA for multiple myeloma

Oct. 26, 2004

Peplin completes phase I study of PEP-005 Topical

Oct. 26, 2004

Karo Bio presents new peptides modulating androgen receptors

Oct. 26, 2004

Avastin receives positive opinion in Europe for metastatic colorectal cancer

Oct. 25, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...